Liu J, Gong LF, Xu YC, Sun ZL, Gao Q, Dong ZJ. Genetic and antigenic characterization of influenza A(H1N1)pdm09 in Yantai, China, during the 2009-2017 influenza season. J Med Virol. 2018 Sep 29.
OBJECTIVE:
This study was performed to determine the antigenic and genetic characteristics and evaluate potential vaccine efficacy of influenza A(H1N1)pdm09 in Yantai from August 2009 to August 2017.
MATERIALS AND METHODS:
A total of 10236 swabs were collected among patients with an influenza-like illness (ILI) who were admitted to 2 sentinel surveillance hospitals in Yantai, East China, from August 2009 to August 2017. All specimens were cultured in Madin-Darby canine kidney cells and identified by haemagglutination inhibition assay. Complete sequences of Haemagglutinin (HA) and Neuraminidase (NA) of fifty-one influenza A(H1N1)pdm09 strains circulating in Yantai were amplified, sequenced and analysed using Molecular and phylogenetic methods. The potential vaccine efficacy was calculated using the p epitope model which measured the antigenic variation based on the changes in the dominant epitope of HA.
RESULTS:
The results showed that most Yantai strains were grouped into genetic clades 1.7, 6C, 6B.1 and 6B.2. The amino acid substitutions accumulated gradually in HA proteins and considerable genetic variation were oberserved in circulating A(H1N1)pdm09 viruses during the seven influenza seasons. The V241I, N369K, N386K and K432E mutations which may change the binding pattern and affinity of oseltamivir for neuraminidase were detected in the strains circulating in 2016/2017 and 2017/2018 seasons and the recommended vaccine strains could afford optimal protection against the influenza A/H1N1pdm09.
CONCLUSIONS:
Although influenza A(H1N1)pdm09 viruses acquired significant genetic variation over the course of 7 influenza seasons, the recommended vaccine strains still afforded protection against main circulating strains. Continuous epidemiological and virological surveillance are necessary.
This study was performed to determine the antigenic and genetic characteristics and evaluate potential vaccine efficacy of influenza A(H1N1)pdm09 in Yantai from August 2009 to August 2017.
MATERIALS AND METHODS:
A total of 10236 swabs were collected among patients with an influenza-like illness (ILI) who were admitted to 2 sentinel surveillance hospitals in Yantai, East China, from August 2009 to August 2017. All specimens were cultured in Madin-Darby canine kidney cells and identified by haemagglutination inhibition assay. Complete sequences of Haemagglutinin (HA) and Neuraminidase (NA) of fifty-one influenza A(H1N1)pdm09 strains circulating in Yantai were amplified, sequenced and analysed using Molecular and phylogenetic methods. The potential vaccine efficacy was calculated using the p epitope model which measured the antigenic variation based on the changes in the dominant epitope of HA.
RESULTS:
The results showed that most Yantai strains were grouped into genetic clades 1.7, 6C, 6B.1 and 6B.2. The amino acid substitutions accumulated gradually in HA proteins and considerable genetic variation were oberserved in circulating A(H1N1)pdm09 viruses during the seven influenza seasons. The V241I, N369K, N386K and K432E mutations which may change the binding pattern and affinity of oseltamivir for neuraminidase were detected in the strains circulating in 2016/2017 and 2017/2018 seasons and the recommended vaccine strains could afford optimal protection against the influenza A/H1N1pdm09.
CONCLUSIONS:
Although influenza A(H1N1)pdm09 viruses acquired significant genetic variation over the course of 7 influenza seasons, the recommended vaccine strains still afforded protection against main circulating strains. Continuous epidemiological and virological surveillance are necessary.
See Also:
Latest articles in those days:
- Identification and characterization of a broadly neutralizing and protective nanobody against the HA1 domain of H5 avian influenza virus hemagglutinin 16 hours ago
- Influenza Vaccine Effectiveness among Primary and Secondary School Students in Shenzhen during the 2023/24 Influenza Season 16 hours ago
- Immunogenicity and protective efficacy of an inactivated bivalent vaccine containing two recombinant H1N1 and H3N2 swine influenza virus strains 16 hours ago
- Neutralizing monoclonal antibodies as effective therapeutics and prophylactics against lethal H10N7 avian influenza infection in a mouse model 2 days ago
- The Ongoing Epidemics of Seasonal Influenza A(H3N2) in Hangzhou, China, and Its Viral Genetic Diversity 2 days ago
[Go Top] [Close Window]